Using the structured dataset, we found that patients exhibiting both very low progesterone receptor (PR) levels and very high tumor cell growth (Ki-67 ≥ 40%) had significantly worse outcomes than other luminal breast cancers. This evidence concerns the gene PGR and breast cancer.